Omaxe Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
OMAXE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Omaxe Limited has informed the exchanges that its Board of Directors will meet on Wednesday, May 28, 2025, to consider and approve the audited financial results (both standalone and consolidated) for the quarter and financial year ended March 31, 2025. In line with SEBI's insider trading regulations and the company's own code of conduct, the trading window for dealing in Omaxe equity shares remains closed. It was shut from April 1, 2025 and will stay closed until the end of business hours on May 30, 2025. This is a standard pre-earnings compliance filing, and no other business items have been disclosed at this stage.
This is a routine regulatory filing that signals the upcoming release of Q4 and full-year FY25 earnings, which is a key event for shareholders. The trading window closure means insiders, promoters and designated employees cannot buy or sell Omaxe shares until May 30, 2025, so retail investors should watch for the audited results announcement around May 28-30 for fresh fundamental cues.